Regulatory Services

Navigate regulatory requirements for clinical studies with confidence

Specialist regulatory support for IVD and companion diagnostic studies, from early study strategy and planning through study conduct and close-out.

image of job applicants in a discussion (for a medical clinic)
image of ai software in healthcare action in a lab environment
[background image] image of a workplace setting (for an ai healthcare company)

The Regulatory Challenge

Complex requirements can create delays and unnecessary risk

ARC helps diagnostic developers understand regulatory expectations, identify evidence gaps and maintain alignment across product development, clinical delivery and submission planning.

image of pharmacy community engagement activities
Unclear regulatory pathways

Product classification, intended use and submission routes can vary significantly between markets.

Evidence expectations

Scientific validity, analytical performance and clinical performance requirements must be understood early.

Submission complexity

Technical and clinical documentation must remain complete, consistent and aligned with the intended claims.

Evolving requirements

Regulatory expectations continue to change across the UK, European Union, United States and other global markets.

Our Regulatory Services

What we can take on

ARC provides flexible regulatory support, from targeted input on a specific challenge to integrated delivery across the full diagnostic product lifecycle.

  • Regulatory strategy and pathway planning

  • Product classification, intended use and claims

  • Regulatory gap assessments

  • Global market and registration planning

  • FDA pre-submission and authority engagement

  • EU IVDR, UKCA and MHRA support

  • US and international regulatory submissions

  • Scientific validity and performance evaluation documentation

  • Clinical performance study protocols and reports

  • Post-market, lifecycle and regulatory intelligence support

  • Regulatory and quality alignment

Our Regulatory Capabilities

Specialist regulatory support for clinical studies

From early study planning and evidence strategy through clinical-study submissions, ARC provides practical regulatory expertise tailored to your programme.

Regulatory Strategy and Planning

Develop a clear regulatory pathway aligned with your product, intended use, stage of development and target markets.
  • Product classification
  • Intended use and claims strategy
  • Regulatory pathway assessment
  • Target market planning
  • Regulatory gap analysis
  • Development and submission roadmaps

Regulatory Authority Engagement

Prepare for productive interactions with regulatory authorities throughout development and review.
  • FDA pre-submissions
  • Authority meeting strategy
  • Question development
  • Briefing documentation
  • Meeting preparation and attendance
  • Follow-up and response planning
Evidence and Study Strategy
Ensure that the evidence generated during development supports the intended regulatory pathway and product claims.
  • Scientific validity strategy
  • Analytical performance planning
  • Clinical performance strategy
  • Evidence gap assessments
  • Study design input
  • Alignment of endpoints and acceptance criteria
  • Clinical evidence planning
Regulatory Submissions
Prepare clear, complete and consistent submission packages for diagnostic products across key markets.
  • EU IVDR technical documentation
  • FDA submission support
  • UKCA and MHRA support
  • International registration submissions
  • Submission planning and coordination
  • Document review and remediation
  • Responses to authority questions
  • Post-submission support
Medical and Regulatory Writing
Translate complex scientific and clinical information into clear, compliant regulatory documentation.
  • IVD and CDx study protocols
  • Scientific validity reports
  • Performance evaluation plans
  • Performance evaluation reports
  • Clinical performance study reports
  • Investigator brochures
  • Clinical monitoring plans
  • Submission summaries
Lifecycle and Compliance Support
Maintain regulatory compliance as products, evidence, manufacturing processes and market requirements evolve.
  • Regulatory change assessments
  • Submission maintenance
  • Market expansion planning
  • Post-market documentation
  • Regulatory intelligence
  • Product lifecycle strategy
  • Ongoing authority interactions
End-to-End Regulatory Support

Supporting your product from concept to post-market

Regulatory guidance aligned with each stage of diagnostic development.

01

Concept

Product classification, intended use, target markets and early pathway assessment.

02

Development

Regulatory strategy, claims development and evidence planning.

03

Evidence Generation

Scientific validity, analytical performance and clinical performance strategy.

04

Submission

Technical documentation, submission preparation and authority engagement.

05

Review and Approval

Responses to regulatory questions and support throughout the review process.

06

Post-Market

Change assessments, submission maintenance and ongoing lifecycle compliance.

Global Regulatory Support

Global reach, supported by local expertise

ARC supports precision medicine clinical trialsthrough an extensive talent pool to deliverlocal expertise in a global study context.​

World map showing ARC's international team and established delivery network
Resources United States
Headquarters Northern Ireland
Resources China
Resources Singapore
Headquarters

Northern Ireland

Resources

United States

Resources

China

Resources

Singapore

Geographic coverage reflects ARC’s internal team and established delivery network. Regulatory support is tailored to each programme and target market.

Why ARC Regulatory

Connected expertise, practical delivery

‍

Diagnostic specialists

Focused experience across IVD, CDx and precision medicine programmes.

Connected capabilities

Regulatory, clinical, laboratory and medical writing expertise within one team.

Tailored strategies

Regulatory pathways shaped around your product, development stage and target markets.

Flexible partnership

Targeted support for one activity or integrated support across the lifecycle.

RELATED INSIGHTS

Latest Thinking in Dx CRO

Explore expert perspectives, industry developments, and practical guidance across clinical research and CRO services.

Expert Q&A

Answers to Your Questions

When should regulatory planning begin?

Regulatory planning should begin as early as possible, ideally before key product-development, validation and clinical study decisions are finalised.

Can ARC support both regulatory strategy and delivery?

Yes. ARC can provide strategic pathway guidance as well as hands-on support with evidence planning, regulatory documentation, submissions and authority interactions.

Which markets can ARC support?

ARC provides regulatory support across key markets, including the UK, European Union and United States, alongside wider international planning where appropriate.

Can ARC support FDA pre-submissions?

Yes. ARC can assist with meeting strategy, question development, briefing documentation, meeting preparation and follow-up activities.

Can ARC support EU IVDR requirements?

Yes. Support can include regulatory strategy, performance evaluation, technical documentation and wider submission-readiness activities under the EU IVDR.

Why ARC?

Specialist expertise in precision medicine trials, regulatory compliance and clinical operations.

Connected Programme Support

Explore our other services

ARC brings together regulatory, clinical, laboratory and technology expertise to support diagnostic programmes from development through delivery.

Contact ARC Regulatory

How can we help?

The ARC team welcomes the opportunity to connect with you, share our real-life experiences and help navigate your business as you find kinder patient treatments.